SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-18-006578
Filing Date
2018-08-07
Accepted
2018-08-07 16:04:02
Documents
80
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q nviv-20180630x10q.htm 10-Q 1264929
2 EX-31.1 nviv-20180630ex311df628b.htm EX-31.1 15119
3 EX-31.2 nviv-20180630ex312d07845.htm EX-31.2 14656
4 EX-32.1 nviv-20180630ex32159e6f2.htm EX-32.1 8158
5 EX-32.2 nviv-20180630ex322937397.htm EX-32.2 8049
  Complete submission text file 0001558370-18-006578.txt   6020183

Data Files

Seq Description Document Type Size
6 EX-101.INS nviv-20180630.xml EX-101.INS 1140378
7 EX-101.SCH nviv-20180630.xsd EX-101.SCH 48567
8 EX-101.CAL nviv-20180630_cal.xml EX-101.CAL 44325
9 EX-101.DEF nviv-20180630_def.xml EX-101.DEF 220878
10 EX-101.LAB nviv-20180630_lab.xml EX-101.LAB 474770
11 EX-101.PRE nviv-20180630_pre.xml EX-101.PRE 397583
Mailing Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139 617-863-5524
INVIVO THERAPEUTICS HOLDINGS CORP. (Filer) CIK: 0001292519 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37350 | Film No.: 18997925
SIC: 3841 Surgical & Medical Instruments & Apparatus
Office of Life Sciences